Aurore ANDRE, CEO of Azapharm joins the strategic board of Apmonia Therapeutics, a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.
September, 2022 Aurore ANDRE, CEO of Azapharm joins the strategic board of Apmonia Therapeutics, a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia’s strategic board comprises experts in biotech, business, funding and more, who harness their experience to support the company’s innovation and growth. “I am pleased to welcome Aurore to our strategic board. We believe the experience and knowledge she brings…